Funding · Company
Rezo Therapeutics, Inc.
San Francisco, CABiotech & Pharma
Rezo Therapeutics, Inc. of San Francisco, CA has disclosed $68M across 1 Form D offering filed with the SEC on Aug 18, 2025.
$68M
Total disclosed
1
Form D offering
1
Open roles today
Hiring — 1 open role as of Sep 23, 2026
Mostly Research & Development (1). Based in San Francisco, CA. Counted from the company's own public job board.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$68M
Form D · Aug 18, 2025 ↗
Q3 2025
· 2 amendments, first filed Dec 1, 2022
· target $80M
Filing details
HeadquartersSan Francisco, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0001956559Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →